Privacy in the Post Roe v. Wade World: How Could Proposed HIPAA Restrictions on Reproductive PHI Affect Labs?
Key points labs should know about the recently proposed OCR rule on privacy protections for PHI associated with reproductive health care.
An analysis of recent OCR enforcement actions and settlements identifies the common pitfalls labs should watch out for.
Diana W. Bianchi, MD, discusses how NIPT has evolved, key challenges, as well as her team’s research on using these tests to detect cancer.
Genomic sequencing is almost twice as likely to yield a diagnostic result, but lags behind panel testing in speed, cost, and concordance.
Using LIMS and no-code solutions can unlock opportunities for efficiency.
Tackling the challenges of “forever chemicals” in the diagnostics industry.
Here are what G2 Intelligence considers the three most significant deals announced in the period from late August to early September.
Lab leaders are at the greatest risk of HIPAA violations when they get complacent about privacy training.
This template helps lab leaders implement a written policy limiting and establishing procedures governing use of PHI for marketing.
This template helps labs create a fact sheet that highlights the key HIPAA-related do’s and don’ts for marketing staff.